CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS
Objective: to investigate the levels and clinical associations of vascular endothelial growth factor (VEGF) and its type 2 receptor (VEGFR-2) in patients with systemic sclerosis (SSc).Subjects and methods. The investigation enrolled 46 patients aged 19–77 years with SSc lasting 0.5–24 years. This gr...
Saved in:
| Main Authors: | R. T. Alekperov, L. P. Ananyeva, M. V. Cherkasova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2018-11-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2619 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis
by: Angelo Zinellu, et al.
Published: (2024-11-01) -
Effects of water training with betaine supplementation on vascular endothelial growth factor and oxidative stress markers in the cerebellum of rats with multiple sclerosis
by: Masoud Moradi, et al.
Published: (2025-03-01) -
Vascular growth factors in hypertensive state pathogenesis
by: O. A. Gomazkov
Published: (2005-06-01) -
Endothelial periostin regulates vascular remodeling by promoting endothelial dysfunction in pulmonary arterial hypertension
by: Dawn Lee, et al.
Published: (2024-12-01) -
Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)